<?xml version="1.0" encoding="UTF-8"?>
<p>Favipiravir is an RNA polymerase inhibitor that is used for the treatment of influenza in China. Favipiravir is able to block the replication of RNA viruses by blocking the RNA-dependent RNA polymerase (RdRp) enzyme. Therefore, favipiravir may have antiviral activity against SARS-CoV-2, which is also an RNA virus (
 <xref rid="B102" ref-type="bibr">102</xref>). Clinic trials involving the use of this drug in treating SARS-CoV-2 infection are currently ongoing.
</p>
